Subcortical hyperintensity volumetrics in Alzheimer's disease and normal elderly in the Sunnybrook Dementia Study: Correlations with atrophy, executive function, mental processing speed, and verbal memory

Alzheimer's Research and Therapy

Volumn 6, Issue 4, 2014, Pages

  Ramirez, Joel ^a,b,c   McNeely, Alicia A ^a,b,c   Scott, Christopher Jm ^a,b,c   Stuss, Donald T ^d,e,f   Black, Sandra E ^a,b,c,d,e  

^a LC Campbell Cognitive Neurology Research Unit   (Canada)

^b HEART AND STROKE FOUNDATION OF CANADA   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e ROTMAN RESEARCH INSTITUTE   (Canada)

^f Ontario Brain Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; ATROPHY; BRAIN ATROPHY; CEREBROSPINAL FLUID; CEREBROVASCULAR DISEASE; COGNITION; CONTROLLED STUDY; DEMENTIA; EXECUTIVE FUNCTION; FEMALE; GERIATRIC PATIENT; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NUCLEAR MAGNETIC RESONANCE IMAGING; VERBAL MEMORY; WHITE MATTER;

EID: 84908447608     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt279     Document Type: Article

References (83)

1. FLAIR histogram segmentation for measurement of leukoaraiosis volume. Jack CR Jr, O'Brien PC, Rettman DW, Shiung MM, Xu Y, Muthupillai R, Manduca A, Avula R, Erickson BJ, J Magn Reson Imaging 2001 14 668 676
2. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, De Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge R, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, et al. Lancet Neurol 2013 12 822 838
3. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Pantoni L, Lancet Neurol 2010 9 689 701
4. Leukoaraiosis. O'Sullivan M, Pract Neurol 2008 8 26 38
5. Leuko-araiosis. Hachinski VC, Potter P, Merskey H, Arch Neurol 1987 44 21 23
6. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. De Groot JC, De Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM, Neurology 2001 56 1539 1545
7. Correlations between MRI white matter lesion location and executive function and episodic memory. Smith EE, Salat DH, Jeng J, McCreary CR, Fischl B, Schmahmann JD, Dickerson BC, Viswanathan A, Albert MS, Blacker D, Greenberg SM, Neurology 2011 76 1492 1499
8. Cognitive associations of subcortical white matter lesions in older people. O'Brien JT, Wiseman R, Burton EJ, Barber B, Wesnes K, Saxby B, Ford GA, Ann N Y Acad Sci 2002 977 436 444
9. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Burton EJ, Kenny RA, O'Brien J, Stephens S, Bradbury M, Rowan E, Kalaria R, Firbank M, Wesnes K, Ballard C, Stroke 2004 35 1270 1275
10. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. van den Heuvel DM, ten Dam VH, de Craen AJ, Admiraal-Behloul F, Olofsen H, Bollen EL, Jolles J, Murray HM, Blauw GJ, Westendorp RG, van Buchem MA, J Neurol Neurosurg Psychiatry 2006 77 149 153
11. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Au R, Massaro JM, Wolf PA, Young ME, Beiser A, Seshadri S, D'Agostino RB, Decarli C, Arch Neurol 2006 63 246 250
12. Gait and subcortical hyperintensities in mild Alzheimer's disease and aging. Nadkarni NK, McIlroy WE, Mawji E, Black SE, Dement Geriatr Cogn Disord 2009 28 295 301
13. Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia. Swartz RH, Stuss DT, Gao F, Black SE, Stroke 2008 39 822 830
14. Should we distinguish between periventricular and deep white matter hyperintensities? Sachdev P, Wen W, Stroke 2005 36 2342 2343
15. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Decarli C, Fletcher E, Ramey V, Harvey D, Jagust WJ, Stroke 2005 36 50 55
16. Different progression rates for deep white matter hyperintensities in elderly men and women. van den Heuvel DM, Admiraal-Behloul F, Ten DV, Olofsen H, Bollen EL, Murray HM, Blauw GJ, Westendorp RG, de Craen AJ, van Buchem MA, Neurology 2004 63 1699 1701
17. Misclassified tissue volumes in Alzheimer disease patients with white matter hyperintensities: importance of lesion segmentation procedures for volumetric analysis. Levy-Cooperman N, Ramirez J, Lobaugh NJ, Black SE, Stroke 2008 39 1134 1141
18. Lesion explorer: a comprehensive segmentation and parcellation package to obtain regional volumetrics for subcortical hyperintensities and intracranial tissue. Ramirez J, Gibson E, Quddus A, Lobaugh NJ, Feinstein A, Levine B, Scott CJ, Levy-Cooperman N, Gao FQ, Black SE, Neuroimage 2011 54 963 973
19. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, Decarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG, Stroke 2006 37 2220 2241
20. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH, Alzheimers Dement 2011 7 263 269
21. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders Washington, DC: American Psychiatric Association 4 1994
22. Lesack MD, Neuropsychological Assessment New York: Oxford University Press 1983
23. Heaton RK, Wisconsin Card Sorting Test manual Odessa, Florida: Psychological Assessment Resources 1981
24. Reitan RM, Wolfson DB, The Halstead-Reitan Neuropsychological Test Battery: Theory and clinical interpretation Tucson, AZ: Neuropsychological Press 1985
25. Delis DC, Kramer JH, Kaplan E, Ober BA, The California Verbal Learning Test San Antonio: The Psychological Corporation 2 2000
26. Wechsler D, Wechsler Memory Scale-Revised New York: The Psychological Corporation 1987
27. Mental status examination for organic mental syndrome in the elderly patient. Mattis S, Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians New York: Grune & Stratton, Bellak L, Karasu TB, 1976 77 121
28. A short-term scan-rescan reliability test measuring brain tissue and subcortical hyperintensity volumetrics obtained using the lesion explorer structural MRI processing pipeline. Ramirez J, Scott CJ, Black SE, Brain Topogr 2013 26 35 38
29. A robust method for extraction and automatic segmentation of brain images. Kovacevic N, Lobaugh NJ, Bronskill MJ, Levine B, Feinstein A, Black SE, Neuroimage 2002 17 1087 1100
30. Semiautomatic brain region extraction: a method of parcellating brain regions from structural magnetic resonance images. Dade LA, Gao FQ, Kovacevic N, Roy P, Rockel C, O'Toole CM, Lobaugh NJ, Feinstein A, Levine B, Black SE, Neuroimage 2004 22 1492 1502
31. Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. Blatter DD, Bigler ED, Gale SD, Johnson SC, Anderson CV, Burnett BM, Parker N, Kurth S, Horn SD, AJNR Am J Neuroradiol 1995 16 241 251
32. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, Fogarty J, Bartha R, Brain 2008 131 2443 2454
33. Ventricular volume and dementia progression in the Cardiovascular Health Study. Carmichael OT, Kuller LH, Lopez OL, Thompson PM, Dutton RA, Lu A, Lee SE, Lee JY, Aizenstein HJ, Meltzer CC, Liu Y, Toga AW, Becker JT, Neurobiol Aging 2007 28 389 397
34. Ventricular enlargement and its clinical correlates in the imaging cohort from the ADCS MCI donepezil/vitamin E study. Apostolova LG, Babakchanian S, Hwang KS, Green AE, Zlatev D, Chou YY, Decarli C, Jack CR Jr, Petersen RC, Aisen PS, Cummings JL, Toga AW, Thompson PM, Alzheimer Dis Assoc Disord 2013 27 174 181
35. Mini Mental State. A practical method for grading the cognitive state of patients for the clinician. Folstein MF, Folstein SE, McHugh PR, J Psychiatr Res 1975 12 189 198
36. Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect. Boone KB, Miller BL, Lesser IM, Mehringer CM, Hill-Gutierrez E, Goldberg MA, Berman NG, Arch Neurol 1992 49 549 554
37. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Liao D, Cooper L, Cai J, Toole JF, Bryan NR, Hutchinson RG, Tyroler HA, Stroke 1996 27 2262 2270
38. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Manolio TA, Kronmal RA, Burke GL, Poirier V, O'Leary DH, Gardin JM, Fried LP, Steinberg EP, Bryan RN, Stroke 1994 25 318 327
39. Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Schmidt R, Fazekas F, Kleinert G, Offenbacher H, Gindl K, Payer F, Freidl W, Niederkorn K, Lechner H, Arch Neurol 1992 49 825 827
40. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Decarli C, Murphy DG, Tranh M, Grady CL, Haxby JV, Gillette JA, Salerno JA, Gonzales-Aviles A, Horwitz B, Rapoport SI, Neurology 1995 45 2077 2084
41. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Gunning-Dixon FM, Raz N, Neuropsychology 2000 14 224 232
42. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L, Stroke 1996 27 1274 1282
43. Hypertension in the elderly is associated with white matter lesions and cognitive decline. van Swieten JC, Geyskes GG, Derix MM, Peeck BM, Ramos LM, van Latum JC, van GJ, Ann Neurol 1991 30 825 830
44. Brain white-matter changes in the elderly prone to falling. Masdeu JC, Wolfson L, Lantos G, Tobin JN, Grober E, Whipple R, Amerman P, Arch Neurol 1989 46 1292 1296
45. White matter hyperintensities are related to physical disability and poor motor function. Sachdev PS, Wen W, Christensen H, Jorm AF, J Neurol Neurosurg Psychiatry 2005 76 362 367
46. Brain white matter lesions detected by magnetic resonance imaging are associated with balance and gait speed. Starr JM, Leaper SA, Murray AD, Lemmon HA, Staff RT, Deary IJ, Whalley LJ, J Neurol Neurosurg Psychiatry 2003 74 94 98
47. A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Whitman GT, Tang Y, Lin A, Baloh RW, Neurology 2001 57 990 994
48. Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Steingart A, Hachinski VC, Lau C, Fox AJ, Fox H, Lee D, Inzitari D, Merskey H, Arch Neurol 1987 44 36 39
49. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R, Arch Neurol 1993 50 818 824
50. White matter hyperintensities and cognitive dysfunction in Alzheimer disease. Heo JH, Lee ST, Kon C, Park HJ, Shim JY, Kim M, J Geriatr Psychiatry Neurol 2009 22 207 212
51. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study. Brun A, Englund E, Ann Neurol 1986 19 253 262
52. Rethinking vascular dementia. Erkinjuntti T, Hachinski V, Cerebrovas Dis 1993 3 3 23
53. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Fein G, Di SV, Tanabe J, Cardenas V, Weiner MW, Jagust WJ, Reed BR, Norman D, Schuff N, Kusdra L, Greenfield T, Chui H, Neurology 2000 55 1626 1635
54. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Mungas D, Jagust WJ, Reed BR, Kramer JH, Weiner MW, Schuff N, Norman D, Mack WJ, Willis L, Chui HC, Neurology 2001 57 2229 2235
55. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Vermeer SE, Den HT, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM, Stroke 2003 34 392 396
56. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Carmichael O, Schwarz C, Drucker D, Fletcher E, Harvey D, Beckett L, Jack CR Jr, Weiner M, Decarli C, Arch Neurol 2010 67 1370 1378
57. Associations between magnetic resonance imaging measures and neuropsychological impairment in early and late onset alzheimer's disease. van der Vlies AE, Staekenborg SS, Admiraal-Behloul F, Prins ND, Barkhof F, Vrenken H, Reiber JH, Scheltens P, van der Flier WM, J Alzheimers Dis 2013 35 169 178
58. White matter hyperintensities in dementia: does it matter? Wahlund LO, Basun H, Almkvist O, Andersson-Lundman G, Julin P, Saaf J, Magn Reson Imaging 1994 12 387 394
59. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. Gootjes L, Teipel SJ, Zebuhr Y, Schwarz R, Leinsinger G, Scheltens P, Moller HJ, Hampel H, Dement Geriatr Cogn Disord 2004 18 180 188
60. Impact of white matter changes on clinical manifestation of Alzheimer's disease: A quantitative study. Hirono N, Kitagaki H, Kazui H, Hashimoto M, Mori E, Stroke 2000 31 2182 2188
61. Functions of the frontal lobes: relation to executive functions. Stuss DT, J Int Neuropsychol Soc 2011 17 759 765
62. The effects of focal anterior and posterior brain lesions on verbal fluency. Stuss DT, Alexander MP, Hamer L, Palumbo C, Dempster R, Binns M, Levine B, Izukawa D, J Int Neuropsychol Soc 1998 4 265 278
63. A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia. Bocti C, Swartz RH, Gao FQ, Sahlas DJ, Behl P, Black SE, Stroke 2005 36 2126 2131
64. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients. Behl P, Bocti C, Swartz RH, Gao F, Sahlas DJ, Lanctot KL, Streiner DL, Black SE, Arch Neurol 2007 64 266 272
65. Strategic involvement of cholinergic pathways correlates with visuospatial and executive dysfunction: Does the location of white matter signal hyperintensities matter? Swartz RH, Sahlas DJ, Black SE, J Stroke Cerebrovasc Dis 2003 12 29 36
66. The effect of ischemic cholinergic damage on cognition in patients with subcortical vascular cognitive impairment. Kim SH, Kang HS, Kim HJ, Moon Y, Ryu HJ, Kim MY, Han SH, J Geriatr Psychiatry Neurol 2012 25 122 127
67. Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia. Kim HJ, Moon WJ, Han SH, J Alzheimers Dis 2013 35 129 136
68. White matter changes compromise prefrontal cortex function in healthy elderly individuals. Nordahl CW, Ranganath C, Yonelinas AP, Decarli C, Fletcher E, Jagust WJ, J Cogn Neurosci 2006 18 418 429
69. Is the whole brain periventricular? Barkhof F, Scheltens P, J Neurol Neurosurg Psychiatry 2006 77 143 144
70. Wide variation in definition, detection, and description of lacunar lesions on imaging. Potter GM, Marlborough FJ, Wardlaw JM, Stroke 2011 42 359 366
71. Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging. Bastos Leite AJ, van Straaten EC, Scheltens P, Lycklama G, Barkhof F, Stroke 2004 35 415 419
72. White matter hyperintensities in mid-adult life. Sachdev P, Chen X, Wen W, Curr Opin Psychiatry 2008 21 268 274
73. A new rating scale for age-related white matter changes applicable to MRI and CT. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P, Stroke 2001 32 1318 1322
74. CT and MRI rating of white matter lesions. Fazekas F, Barkhof F, Wahlund LO, Pantoni L, Erkinjuntti T, Scheltens P, Schmidt R, Cerebrovasc Dis 2002 13 31 36
75. White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on age-related white matter changes. Scheltens P, Erkinjuntti T, Leys D, Wahlund LO, Inzitari D, del Ser T, Pasquier F, Barkhof F, Mantyla R, Bowler J, Wallin A, Ghika J, Fazekas F, Pantoni L, Eur Neurol 1998 39 80 89
76. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. De Groot JC, De Leeuw FE, Oudkerk M, van Gijn J, Hofman A, Jolles J, Breteler MMB, Ann Neurol 2000 47 145 151
77. Understanding white matter disease: Imaging-pathological correlations in vascular cognitive impairment. Black SE, Gao FQ, Bilbao J, Stroke 2009 40 48 S52
78. Periventricular venous collagenosis: association with leukoaraiosis. Moody DM, Brown WR, Challa VR, Anderson RL, Radiology 1995 194 469 476
79. Venous collagenosis and arteriolar tortuosity in leukoaraiosis. Brown WR, Moody DM, Challa VR, Thore CR, Anstrom JA, J Neurol Sci 2002 203-204 159 163
80. Cerebrovascular pathology in Alzheimer's disease and leukoaraiosis. Brown WR, Moody DM, Thore CR, Challa VR, Ann N Y Acad Sci 2000 903 39 45
81. Microvascular changes in the white mater in dementia. Brown WR, Moody DM, Thore CR, Anstrom JA, Challa VR, J Neurol Sci 2009 283 28 31
82. Counting cavitating lacunes underestimates the burden of lacunar infarction. Potter GM, Doubal FN, Jackson CA, Chappell FM, Sudlow CL, Dennis MS, Wardlaw JM, Stroke 2010 41 267 272
83. Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls. Barnes J, Carmichael OT, Leung KK, Schwarz C, Ridgway GR, Bartlett JW, Malone IB, Schott JM, Rossor MN, Biessels GJ, Decarli C, Fox NC, Neurobiol Aging 2013 34 1996 2002